Prothena Corp Public LTD paid its 5 named executives $16.2M in total in FY2025 (Dec). CEO Gene G. Kinney, Ph.D. was paid $5.9M of that.
Pay$100 in the stock at the end of FY20 → $346
Pay of each named executive
Gene G. Kinney, Ph.D.President and Chief Executive Officer
| FY2025 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
3 years
Brandon S. SmithChief Operating Officer
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Tran B. NguyenChief Strategy Officer and Chief Financial Officer
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Chad J. Swanson, Ph.DChief Dev. Officer
| FY2025 (Dec) |
1 year
Wagner M. Zago, Ph.D.Chief Scientific Officer
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) |
2 years
CEO pay against the pay peers
In FY2023 (Dec), the median CEO pay of the 9 peers with pay on file was $7.5M. The CEO of Prothena Corp Public LTD was paid $7.0M, 6% below the median.
- 1Arcus Biosciences
- 2Cytokinetics
- 3Celldex Therapeutics
- 4Denali Therapeutics
- 5Anaptysbio
- 6Prothena Corp Public LTDThis company
- 7Krystal Biotech
- 8Kura Oncology
- 9Iovance Biotherapeutics
- 10Replimune Group
- 11AlectorNot disclosed
- 12Anavex Life SciencesNot disclosed
- 13Arrowhead PharmaceuticalsNot disclosed
- 14Crinetics PharmaceuticalsNot disclosed
- 15ImmunoGenNot disclosed
- 16Karuna TherapeuticsNot disclosed
- 17Kodiak SciencesNot disclosed
- 18Mersana TherapeuticsNot disclosed
- 19NGM BiopharmaceuticalsNot disclosed
- 20Sangamo TherapeuticsNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.